Immuno-suppressant therapy for Type 1 Diabetes Mellitus

Research has shown that CD3 positive T cells are the main type of T cell involved in attacking the pancreas. Monoclonal antibodies hOKT3$\gamma$1 (Ala-Ala) termed anti-CD3 have been used in clinincal trials of people with newly diagnosed diabetes.